BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This material consists of hollow mesoporous silica nanoparticles (HMSN) encapsulated with the organic guest sorafenib. The hollow interior provides a high loading capacity, while the mesoporous structure allows for a controlled diffusion process. This design is engineered to protect the encapsulated compound from environmental degradation and to serve as a model for studying the structural performance of hollow porous delivery vehicles in material science.
Source
Custom synthesis
Partical Size
100 nm, 150 nm, 200 nm, 300 nm
Functional Group
Sorafenib
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Applications
This product is used as a model system for investigating guest release in porous media and as a specialized additive in smart material research. It also serves as a research tool for studying hydrophobic guest loading in silica hosts.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.